In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

LipoScience succeeds in its second attempt to go public; nets $48.1mm

Executive Summary

After failing to go public in 2002 and refiling in 2011, LipoScience Inc. (diagnostics for cardiovascular and metabolic conditions) has finally completed its IPO. It sold 5.75mm common shares (including the overallotment) at $9--much lower than the $13-15 price it proposed earlier this month--netting $48.1mm.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register